Chinese vaccine could be ready by year-end, government body says
HONG KONG: A Chinese-made coronavirus vaccine could possibly be prepared for market as early as the tip of this 12 months, China’s State-owned Assets Supervision and Administration Commission (SASAC) mentioned in a social media publish.
In trials, greater than 2,000 individuals have obtained vaccines developed by the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products. A vaccine could possibly be prepared for the market as early as the tip of this 12 months or early 2021, based on the May 29 publish on Chinese social media platform WeChat.
Vaccines from the Wuhan Institute of Biological Products and the Beijing Institute of Biological Products had entered Phase II medical trials. Both teams are affiliated with state-owned pharmaceutical group Sinopharm, whose administration is overseen by SASAC.
The Beijing Institute of Biological Products’ manufacturing line can have an annual manufacturing capability of 100 million to 120 million doses, based on the article.
China has 5 coronavirus vaccines in human trials. Neither firm could possibly be reached for touch upon Saturday night.